{"disease":{"id":"neuromyelitis-optica-spectrum-disorder-relapse","name":"neuromyelitis optica spectrum disorder relapse"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04131764","title":"Diagnosis of ON With or Without MS or NMOSD","phase":"","overall_status":"TERMINATED","enrollment_count":112,"lead_sponsor_name":"Jagannadha R Avasarala","has_results":false},{"nct_id":"NCT05909943","title":"Efficacy and Safety of Ruxolitinib in Neuromyelitis Optica Spectrum Disorders","phase":"PHASE1, PHASE2","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Tianjin Medical University General Hospital","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}